PBA Stock Analysis: Pembina Pipeline | NYSE
Oil & Gas Midstream | NYSE, USA | Market Cap: 28.264m USD | 12M Return: 31.3% | CA7063271034 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 48.0M
EPS Trend: -41.1%
Qual. Beats: 0
Rev. Trend: -29.0%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Pembina Pipeline Corporation (NYSE: PBA) is a Calgary-based Canadian energy company that provides energy transportation and midstream services across North America. Founded in 1954 and listed on the NYSE in October 2010, the company operates through three segments: Pipelines, Facilities, and Marketing & New Ventures. The Pipelines segment transports crude oil, oil sands, and heavy oil via conventional and transmission systems. The Facilities segment provides gathering, processing, fractionation, and storage infrastructure for crude oil, natural gas, condensate, and natural gas liquids (NGLs) such as ethane, propane, and butane, and includes a liquefied propane export facility. The Marketing & New Ventures segment trades hydrocarbon liquids and natural gas sourced primarily from the Western Canadian Sedimentary Basin.
As a large-cap stock in the GICS Oil & Gas Storage & Transportation sub-industry, Pembina sits in the midstream segment of the energy value chain, which links upstream oil and gas production to downstream refineries and end markets. The companys integrated business model-spanning pipelines, processing/storage facilities, and marketing-allows it to generate fee-based revenue from infrastructure services while also earning margins from physical hydrocarbon trading.
- Oil sands throughput strengthens Pipelines segment utilization
- NGL fractionation and propane export demand expand Facilities margins
- Capital spending targets low-risk fee-based contracted growth
| Net Income: 1.79b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -0.51 > 1.0 |
| NWC/Revenue: -12.23% < 20% (prev -4.98%; Δ -7.25% < -1%) |
| CFO/TA 0.08 > 3% & CFO 2.89b > Net Income 1.79b |
| Net Debt (14.3b) to EBITDA (3.73b): 3.83 < 3 |
| Current Ratio: 0.62 > 1.5 & < 3 |
| Outstanding Shares: last quarter (582.0m) vs 12m ago 0.0% < -2% |
| Gross Margin: 39.61% > 18% (prev 42.99%; Δ -3.38% > 0.5%) |
| Asset Turnover: 22.12% > 50% (prev 22.85%; Δ -0.73% > 0%) |
| Interest Coverage Ratio: 4.55 > 6 (EBIT TTM 2.75b / Interest Expense TTM 603.4m) |
| A: -0.03 (Total Current Assets 1.57b - Total Current Liabilities 2.54b) / Total Assets 36.3b |
| B: -0.06 (Retained Earnings -2.27b / Total Assets 36.3b) |
| C: 0.08 (EBIT TTM 2.75b / Avg Total Assets 35.8b) |
| D: 0.89 (Book Value of Equity 17.1b / Total Liabilities 19.2b) |
| Altman-Z'' = 1.07 = BB |
| DSRI: 1.30 (Receivables 1.10b/869.0m, Revenue 7.93b/8.09b) |
| GMI: 1.09 (GM 42.99% / 39.61%) |
| AQI: 1.01 (AQ_t 0.31 / AQ_t-1 0.31) |
| SGI: 0.98 (Revenue 7.93b / 8.09b) |
| TATA: -0.03 (NI 1.79b - CFO 2.89b) / TA 36.3b) |
| Beneish M = -2.72 (Cap -4..+1) = A |
As of October 16, 2026, the stock is trading at USD 48.19 with a total of 692,135 shares traded. Over the past week, the price has changed by +2.21%, over one month by +1.95%, over three months by -3.19% and over the past year by +31.27%.
Current recommended Stop Loss: 46.90 (which is 2.7% or 1.4 ATR below the current price).
Pembina Pipeline has received a consensus analysts rating of 3.95. Therefore, it is recommended to buy PBA.
- StrongBuy: 6
- Buy: 6
- Hold: 7
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 46.9 | -2.8% |
Market Cap CAD = 40.1b (28.3b USD * 1.4203 USD.CAD)
P/E Trailing = 23.9409
P/E Forward = 20.3666
P/S = 3.5498
P/B = 2.4387
P/EG = 1.6956
Revenue TTM = 7.93b CAD
EBIT TTM = 2.75b CAD
EBITDA TTM = 3.73b CAD
Long Term Debt = 12.0b CAD (from longTermDebt, last quarter)
Short Term Debt = 1.28b CAD (from shortTermDebt, last quarter)
Debt = 14.4b CAD (from shortLongTermDebtTotal, last quarter) + Leases 594.0m
Net Debt = 14.3b CAD (calculated: Debt 14.4b - CCE 153.1m)
Enterprise Value = 54.4b CAD (40.1b + Debt 14.4b - CCE 153.1m)
Interest Coverage Ratio = 4.55 (Ebit TTM 2.75b / Interest Expense TTM 603.4m)
EV/FCF = 26.38x (Enterprise Value 54.4b / FCF TTM 2.06b)
FCF Yield = 3.79% (FCF TTM 2.06b / Enterprise Value 54.4b)
FCF Margin = 26.01% (FCF TTM 2.06b / Revenue TTM 7.93b)
Net Margin = 22.53% (Net Income TTM 1.79b / Revenue TTM 7.93b)
Gross Margin = 39.61% ((Revenue TTM 7.93b - Cost of Revenue TTM 4.79b) / Revenue TTM)
Gross Margin QoQ = 39.87% (prev 38.48%)
Tobins Q-Ratio = 1.50 (Enterprise Value 54.4b / Total Assets 36.3b)
Interest Expense / Debt = 4.19% (Interest Expense 603.4m / Debt 14.4b)
Taxrate = 22.99% (533.3m / 2.32b)
NOPAT = 2.11b (EBIT 2.75b * (1 - 22.99%))
Current Ratio = 0.62 (Total Current Assets 1.57b / Total Current Liabilities 2.54b)
Debt / Equity = 0.84 (Debt 14.4b / totalStockholderEquity, last quarter 17.1b)
Debt / EBITDA = 3.83 (Net Debt 14.3b / EBITDA 3.73b)
Debt / FCF = 6.91 (Net Debt 14.3b / FCF TTM 2.06b)
Total Stockholder Equity = 16.9b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.98% (Net Income 1.79b / Total Assets 36.3b)
RoE = 10.54% (Net Income TTM 1.79b / Total Stockholder Equity 16.9b)
RoCE = 9.48% (EBIT 2.75b / Capital Employed (Equity 16.9b + L.T.Debt 12.0b))
RoIC = 6.07% (NOPAT 2.11b / Invested Capital 34.8b)
WACC = 5.02% (E(40.1b)/V(54.5b) * Re(5.67%) + D(14.4b)/V(54.5b) * Rd(4.19%) * (1-Tc(0.23)))
Discount Rate = 5.67% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 54.73 | Cagr: 2.55%
[DCF] Terminal Value 74.57% ; FCFF base≈2.12b ; Y1≈2.02b ; Y5≈1.92b
[DCF] Fair Price = 27.50 (EV 30.2b - Net Debt 14.3b = Equity 16.0b / Shares 581.6m; r=8.35% [WACC [floored]]; 5y FCF grow -6.10% → 2.50% )
EPS Correlation: -41.09 | EPS CAGR: -12.10% | SUE: -0.03 | # QB: 0
Revenue Correlation: -29.04 | Revenue CAGR: -0.93% | SUE: 0.83 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.63 | Chg30d=-0.19% | Revisions=-29% | Analysts=4
EPS current Year (2026-12-31): EPS=3.13 | Chg30d=+0.79% | Revisions=+0% | GrowthEPS=+21.8% | GrowthRev=+10.5%
EPS next Year (2027-12-31): EPS=3.20 | Chg30d=+1.67% | Revisions=+36% | GrowthEPS=+2.2% | GrowthRev=+3.5%
[Analyst] Revisions Ratio: +9% (up=11, down=9)